No name

Did you know that schizophrenia affects more than 1 percent of the world's population?

See NARSAD Grants at work on the latest schizophrenia research

Schizophrenia is a severe, chronic, and generally disabling brain and behavior disorder. It is most accurately described as a psychosis - a type of illness that causes severe mental disturbances that disrupt normal thoughts, speech, and behavior. Schizophrenia is believed to be caused by a combination of genetic and environmental factors.

Positive symptoms may include delusions, thought disorders, and hallucinations. People with schizophrenia may hear voices other people don't hear, or believe other people are reading their minds, controlling their thoughts, or plotting to harm them. Negative symptoms may include avolition (a lack of desire or motivation to accomplish goals), lack of desire to form social relationships, and blunted affect and emotion. Cognitive symptoms involve problems with attention and memory, especially in planning and organization to achieve a goal. Cognitive deficits are the most disabling for patients trying to lead a normal life.

learn more about schizophrenia

Visit the Schizophrenia Research Forum, fully sponsored by the Brain & Behavior Research Foundation—a virtual community of scientists collaborating in their quest for causes, improved treatments, and better understanding of schizophrenia.

Visit the Schizophrenia Research Forum for more information about research

 

Andrew Miller, M.D., Emory University Director of Psychiatric Oncology Winship Cancer Institute
Andrew Miller, M.D.
April 18, 2012
An important new development in psychiatry is the growing body of research pointing to the involvement of the immune system in brain and behavior disorders,...
Rachel G. Klein, Ph.D., Professor of Psychiatry NYU Child Study Center
Rachel G. Klein, Ph.D.
April 18, 2012
Founding Member of the Foundation Scientific Council Shares Insight from 33-year Cohort Study with Children: Adolescence is a difficult time for many young...
Paul E Holtzheimer, M.D., M.S.
Paul E Holtzheimer, M.D., M.S.
April 18, 2012
The first placebo-controlled trial to verify the effectiveness and safety of deep brain stimulation (DBS) as a treatment for severe, treatment-resistant...
Carlos A. Zarate, Jr
Carlos A. Zarate, Jr
April 18, 2012
In the most recent series of experiments with the potential to revolutionize the treatment of mood disorders, a team led by NARSAD Independent Investigator...
Fred Volkmar, M.D.,Yale University
Fred Volkmar, M.D.
April 18, 2012
One of the key factors in autism is visual focus. From the time of birth, normal babies are drawn to look at faces, and particularly the top of the face, where...

Pages

Subscribe to